Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Chugai Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

¥7.7 K

2024-10-29

Market Capitalization

¥12.1 T

2024-10-29

Revenue

¥1.3 T

FY, 2025

CreditSafe Score

?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

JPYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue579.8B686.2B786.9B999.8B1.3T1.1T1.2T1.3T
Cost of goods sold246.3B248.3B255.7B338.1B476.3B413.3B339.4B363.7B
Gross profit333.5B437.9B531.3B661.6B783.7B727.2B834.0B903.5B
Gross profit margin, %63.8%67.5%66.2%62.2%65.4%71.2%71.8%
Operating expense total192.6B209.5B212.3B242.3B252.5B288.1B292.0B304.6B
Depreciation and amortization16.6B17.8B17.8B
EBITDA140.9B228.4B319.0B419.4B531.2B439.2B542.0B598.8B
EBITDA margin, %33.3%40.5%41.9%42.2%39.5%46.3%47.6%
EBIT121.0B207.5B299.7B419.3B530.4B439.5B542.6B601.0B
EBIT margin, %30.2%38.1%41.9%42.1%39.5%46.4%47.8%
Interest income83.0M106.0M120.0M166.0M326.0M1.8B2.7B4.3B
Interest expense5.0M126.0M48.0M61.0M26.0M(6.0M)207.0M
Pre tax profit121.4B207.9B298.2B419.4B531.2B443.8B543.0B597.8B
Income tax expense28.4B50.3B83.5B116.4B156.7B118.3B155.7B163.8B
Net Income93.1B157.6B214.7B303.0B374.4B325.5B387.3B434.0B

Footer menu